Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (2010) (ISBN 0309153328) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (2011) (ISBN 0309219299) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) (ISBN 030910078X) Committee on Clinical Trial Registries


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Extending Medicare Reimbursement in Clinical Trials (2000) (ISBN 0309068886) Henry J. Aaron and Hellen Gelband, Editors; Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• The Role of Purchasers and Payers in the Clinical Research Enterprise:Workshop Summary (2002) (ISBN 0309083494) Sean Tunis, Allan Korn, and Alex Ommaya, Editors, Based on a Workshop of the Clinical Research Roundtable, Board on Health Sciences Policy


• A Report on the Sponsors of Cancer Treatment Clinical Trials and Their Approval and Monitoring Mechanisms (1999) (ISBN NI000611)


• Small Clinical Trials: Issues and Challenges (2001) (ISBN 0309073332) Committee on Strategies for Small-Number-Participant Clinical Research Trials, Board on Health Sciences Policy


• Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop Summary (2011) (ISBN 0309212685) Alison Mack and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine; An American Society of Clinical Oncology and Institute of Medicine Workshop


• Informatics Needs and Challenges in Cancer Research: Workshop Summary (2012) (ISBN 0309259487) Sharyl J. Nass and Theresa Wizemann, Rapporteurs; National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine


• Breakthrough Business Models:Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2008) (ISBN 0309120888) Theresa Wizeman, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• Beyond the HIPAA Privacy Rule:Enhancing Privacy, Improving Health Through Research (2009) (ISBN 0309124999) Sharyl J. Nass, Laura A. Levit, and Lawrence O. Gostin, Editors; Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule; Institute of Medicine